10 Surprising Ways Diabetes and Dementia Are Connected
New research reveals a strong link between blood sugar regulation and brain health, showing diabetes significantly increases dementia risk while dementia itself can worsen glucose metabolism.
Scientists continue to uncover an increasingly close relationship between diabetes and dementia. Recent studies show that blood sugar problems affect brain function and vice versa. Here are ten evidence-based insights into how these conditions are interconnected.
People with diabetes are about 60% more likely to develop dementia than those without, and frequent episodes of low blood sugar are linked to a 50% higher risk of cognitive decline. Insulin resistance, the main cause of type 2 diabetes, not only affects the liver and muscles but also the brain. In Alzheimer's disease, this resistance makes it harder for brain cells to use glucose for energy, contributing to cognitive decline.
The brain accounts for only 2% of body weight but uses about 20% of the body's energy. In dementia, brain cells lose the ability to properly use glucose – a condition sometimes unofficially called type 3 diabetes. Conversely, Alzheimer's can raise diabetes risk: patients often have higher fasting blood glucose, and the APOE4 genetic variant, the strongest risk factor for Alzheimer's, reduces insulin sensitivity by trapping insulin receptors inside cells.
Blood vessel damage is another connecting link. Diabetes damages blood vessels, including those in the brain, reducing blood flow and oxygen delivery, and weakens the brain's protective barrier, allowing harmful substances in and causing inflammation. These processes are strongly linked to dementia development.
Interestingly, the dementia drug memantine was originally developed for diabetes. Although it failed to lower blood sugar, researchers later discovered its benefits for brain function. The diabetes drug metformin, one of the most widely used, may reduce brain inflammation and is associated with a lower dementia risk. GLP-1 receptor agonists, such as semaglutide, also lower dementia risk, even more effectively than metformin.
Insulin therapy delivered via nasal spray is being studied as a way to target the brain directly, with small studies showing improvements in memory. SGLT2 inhibitors, a newer class of diabetes drugs that increase sugar removal in urine, may further reduce dementia risk, including Alzheimer's and vascular dementia.
All this evidence suggests that managing diabetes protects not only the heart and kidneys but also the brain. Researchers are still investigating whether these drugs work in people without diabetes, but it is clear that regulating glucose metabolism is important for brain health during aging.
